Cerebral infections in AIDS: Cryptococcal meningitis

Infections in Medicine

Volumn 15, Issue 6, 1998, Pages

  Harrison, Michael J G ^a,c   McArthur, Justin C ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Acquired immune deficiency syndrome (AIDS); Cryptococcus neoformans; Meningitis

Indexed keywords

AMPHOTERICIN B; FLUCYTOSINE;

ANTIFUNGAL ACTIVITY; CRYPTOCOCCUS NEOFORMANS; FUNGAL MENINGITIS; HUMAN; INFECTION PREVENTION; REVIEW; VACCINATION;

EID: 0031806077     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Centers for Disease Control: Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. MMWR 36(suppl 1S):S3-S15, 1987.
2. Desmet P, Kayembe KD, De Vroey C: The value of cryptococcal serum antigen screening among HIV-positive/AIDS patients in Kinshasa, Zaire. AIDS 3:77-78, 1989.
3. Khanna N, Chandramuki A, Desai A, et al: Cryptococcal infections of the central nervous system: An analysis of predisposing factors, laboratory findings and outcome in patients from South India with special reference to HIV infection. J Med Microbiol 45:376-379, 1996.
4. Brodt HR, Kamps BS, Gute P, et al: Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS 11:1731-1738, 1997.
5. Horsburgh CR, Selik RM: Extrapulmonary cryptococcosis in AIDS patients: Risk factors and association with decreased survival. Proceedings from the 28th Interscience Conference on Antimicrobial Agents and Chemotherapy. September-October 1988. Abstract 564.
6. Treseler CB, Sugar AM: Fungal meningitis. Infect Dis Clin North Am 4:789-808, 1990.
7. Gonzalez CE, Shetty D, Lewis LL, et al: Cryptococcosis in human immunodeficiency virus-infected children. Pediatr Infect Dis J 15:796-800, 1996.
8. Larsen RA: Azoles and AIDS. J Infect Dis 162:727-730, 1990.
9. Chuck SL, Sande MA: Infections with C neoformans in acquired immunodeficiency syndrome. N Engl J Med 321:794-799, 1989.
10. Kwartler JA, Linthicum FH, Jahn AF, et al: Sudden hearing loss due to AIDS-related cryptococcal meningitis - A temporal bone study. Otolaryngol Head Neck Surg 104:265-269, 1991.
11. Lipson BK, Freeman WR, Beniz J, et al: Optic neuropathy associated with cryptococcal arachnoiditis in AIDS patients. Am J Ophthalmol 107:523-527, 1989.
12. Golnik KC, Newman SA, Wispelway B: Cryptococcal optic neuropathy in the acquired immune deficiency syndrome. J Clin Neurol Ophthalmol 11:96-103, 1991.
13. Denning DW, Armstrong RW, Lewis BH, et al: Elevated cerebrospinal fluid pressures in patients with cryptococcal meningitis and acquired immunodeficiency syndrome. Am J Med 91:267-272, 1991.
14. Tang LM: Ventriculo-peritoneal shunt in cryptococcal meningitis with hydrocephalus. Surg Neurol 33:314-319, 1990.
15. Sugar AM, Stern JJ, Dupont B: Treatment of cryptococcal meningitis. Rev Infect Dis 12(suppl 3):S338-S348, 1990.
16. Tien RD, Chu PK, Hesselink JR, et al: Intracranial cryptococcosis in immunocompromised patients: CT and MR findings in 29 cases. AJNR 12:283-289, 1991.
17. Mathews VP, Alo PL, Glass JD, et al: AIDS-related CNS cryptococcosis: Radiologic-pathologic correlation. AJNR 13:1477-1486, 1992.
18. Miszkiel KA, Hall-Craggs MA, Miller RF, et al: The spectrum of MRI findings in CNS cryptococcosis in AIDS. Clin Radiol 51:842-850, 1996.
19. Shaunak S, Schell WA, Perfect JR: Cryptococcal meningitis with normal cerebrospinal fluid. J Infect Dis 160:912, 1989.
20. Kovacs JA, Kovacs AA, Polis M, et al: Cryptococcosis in the acquired immunodeficiency syndrome. Ann Intern Med 103:533-538, 1985.
21. Zerpa R, Huicho L, Guillen A: Modified India ink preparation for C neoformans in cerebrospinal fluid specimens. J Clin Microbiol 34:2290-2291, 1996.
22. Nelson MR, Bower M, Smith D, et al: The value of serum cryptococccal antigen in the diagnosis of cryptococcal infection in patients infected with the human immunodeficiency virus. J Infect 21:175-181, 1990.
23. Hoffmann S, Stenderup J, Mathiesen LR: Low yield of screening for cryptococcal antigen by latex agglutination assay on serum and cerebrospinal fluid from Danish patients with AIDS and ARC. Scand J Infect Dis 23:697-702, 1991.
24. Sharkey PK, Graybill JR, Johnson ES, et al: Amphotericin B lipid complex compared with amphotericin B in the treatment of cryptococcal meningitis in patients with AIDS. Clin Infect Dis 22:315-321, 1996.
25. Vincent M, Webster MH, Pether JV: Liposomal amphotericin B. Lancet 339:374-375, 1992.
26. Ringden O, Tollemar J, Tyden G: Liposomal amphotericin B. Lancet 339:374, 1992.
27. Coker RJ, Viviani M, Gazzard BG, et al: Treatment of cryptococcosis with liposomal amphotericin B (AmBisome) in 23 patients with AIDS. AIDS 7:829-835, 1993.
28. Block ER, Jennings AE, Bennett JE: 5-fluorocytosine resistance in C neoformans. Antimicrob Agents Chemother 3:649-656, 1973.
29. Larsen RA, Leal MA, Chan LS: Fluconazole compared with amphotericin B plus flucytosine for cryptococcal meningitis in AIDS: A randomized trial. Ann Intern Med 113:183-197, 1990.
30. Arndt CAS, Walsh TJ, McCully CL, et al: Fluconazole penetration into cerebrospinal fluid: Implications for treating fungal infections of the central nervous system. J Infect Dis 157:178-180, 1988.
31. Denning DW, Tucker RM, Hanson LH, et al: Itraconazole therapy for cryptococcal meningitis and cryptococcosis. Arch Intern Med 149:2301-2308, 1989.
32. de Gans J, Eeftinck Schattenkerk JK, van Ketel RJ: Itraconazole as maintenance treatment for cryptococcal meningitis in the acquired immune deficiency syndrome. Br Med J 296:339, 1988.
33. Witt MD, Lewis RJ, Larsen RA, et al: Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: The role of antifungal susceptibility testing. Clin Infect Dis 22:322-328, 1996.
34. Pozio E, Guarino A, Pignata C, et al: Possible development of resistance to fluconazole during suppressive therapy for AIDS-associated cryptococcal meningitis. Clin Infect Dis 23:1337-1338, 1996.
35. Zuger A, Louie E, Holzman RS, et al: Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. Ann Intern Med 104:234-240, 1986.
36. Dismukes WE, Cloud G, Gallis HA, et al: Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks. N Engl J Med 317:334-341, 1987.
37. Saag MS, Powderly WG, Cloud GA, et al: Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 326:83-89, 1992.
38. van der Horst C, Saag MS, Cloud GA, et al: Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome N Engl J Med 337:15-21, 1997.
39. Sugar AM, Saunders C: Oral fluconazole as suppressive therapy of disseminated cryptococcosis in patients with acquired immunodeficiency syndrome. Am J Med 85:481-489, 1988.
40. Mulanovich VE, Saag MS: Cryptococcal meningitis, in Berger JR, Levy RM (eds): AIDS and the Nervous System. Philadelphia, Lippincott-Raven, 1997, pp 661-675.
41. Zhang H, Zhong Z, Pirofski L-A: Peptide epitopes recognised by a human anti-cryptococcal glucuronoxylomannan antibody. Infect Immun 65:1158-1164, 1997.
42. Manfredi R, Mastroianni A, Coronado OV, et al: Fluconazole as prophylaxis against fungal infection in patients with advanced HIV infection. Arch Intern Med 157:64-69, 1997.